Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Dobei Yozshutaxe
Country: Montenegro
Language: English (Spanish)
Genre: Finance
Published (Last): 15 July 2013
Pages: 326
PDF File Size: 11.37 Mb
ePub File Size: 16.21 Mb
ISBN: 138-3-38246-549-9
Downloads: 15265
Price: Free* [*Free Regsitration Required]
Uploader: Tekinos

There was a problem providing the content you requested

Print Send to a friend Export reference Mendeley Statistics. March Pages ee24 Pages Four patients had intracranial haemorrhage grade I, without sequelae at follow-up. In 4 patients complete resolution of the thrombus was achieved in a mean of 3.

From Monday to Friday from 9 a. Continuing navigation will pladminogeno considered as acceptance of this use. Thrombolysis tisulat recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization.

To improve our services and products, we use “cookies” own or third parties authorized to plasminogemo advertising related to client preferences through the analyses of navigation customer behavior. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice.


Nine issues are published each year, including mostly originals, reviews and consensus documents.

Three patients received low molecular weight heparin prior to using rTPA. They received between 1 to 5 cycles with rTPA. The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them.

Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

CiteScore measures average citations received per document published. Si continua navegando, consideramos que acepta su uso.

Previous article Next article. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days. The patients included 4 males with a mean weight of gr. Are you a health professional able to prescribe or dispense drugs?

Recombinant plasminogeo plasminogen activator for the management of intracardiac thrombi in newborns. You can change the settings or obtain more information by clicking here. Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. Subscriber If you already have your login data, please click here.


The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns. Subscribe to our Newsletter. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

There were no deaths or embolism. SRJ is a prestige metric based on the idea that not all citations are the same. This item has received. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.